MELISSA CAPLAN: Open Payments
NPI 1174501274 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$665 in 36 payments from 16 companies in 2025. Trend: 2023 $95 · 2024 $281 · 2025 $665
Food & beverage: $665
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $112 |
| Daiichi Sankyo Inc. | 6 | $108 |
| Novartis Pharmaceuticals Corporation | 5 | $89 |
| PFIZER INC. | 3 | $74 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| GlaxoSmithKline, LLC. | 2 | $45 |
| BeOne Medicines USA, Inc. | 2 | $32 |
| Deciphera Pharmaceuticals Inc. | 1 | $21 |
| Agios Pharmaceuticals, Inc. | 1 | $20 |
| EMD Serono, Inc. | 1 | $18 |
Products named: Enhertu, IBRANCE, KISQALI, RYBREVANT, ERLEADA, LUTATHERA, BRUKINSA, TAGRISSO.
Industry payments across GA — which companies pay providers there.
